Amerikanische Gesellschaft für Hirudotherapie
Blutungs- / Transfusionsrisiko
Aeromonas-Infektionsrisiko
Nur Einmalgebrauch + Biohazard-Entsorgung

Forschungsbibliothek

Kuratierte Übersichten peer-reviewter Forschung mit Relevanz für die Hirudotherapie

Zuletzt aktualisiert: May 27, 2026Geprüft von: Andrei Dokukin, MD
Forschungswissensdatenbank

ASH structured research registries

In addition to 10051+ long-form research articles below, ASH curates 5 structured registries with cross-linking:

Editorial transparency & research roadmap

ASH treats this library as a living dataset. Current import baseline: 10051 long-form articles plus 449 metadata-imported PubMed/DOI records, with a public 10,000-article ingestion target. The pages below explain how we grade evidence, what PMIDs are still unverified, and where the corpus is going next.

Die ASH-Forschungsbibliothek indexiert derzeit 269 peer-reviewte Publikationen mit Relevanz für die Hirudotherapie und umfasst klinische Studien, mikrochirurgische Ergebnisse, Genomik & Proteomik, Arzneimittelentwicklung, Speichel-Pharmakologie sowie Sicherheit & Infektionskontrolle. Jeder Artikel enthält eine vollständige Zitation sowie – sofern verfügbar – einen Link zur Primärquelle. Eine kuratierte Auswahl (50+ Einträge) ist in Hirudopedia nach Indikation, Evidenzgrad und Studiendesign vollständig annotiert.

Evidenz-Disziplin

Alle Artikel werden anhand der Primärquellen überprüft. Präklinische Forschung wird klar von klinischer Evidenz abgegrenzt. Der regulatorische Kontext (FDA-zugelassen vs. experimentell) wird, soweit zutreffend, vermerkt.

Forschungskategorien

Antimikrobielle Resistenz

AMPs, Antibiotika-Synergie und neuartige Ansätze gegen arzneimittelresistente Pathogene.

248 Artikel

Speichel-Pharmakologie

Bioaktive Verbindungen im Blutegelspeichel – Entdeckung, Charakterisierung und therapeutisches Potenzial.

967 Artikel

Arzneimittelentwicklung

Translation blutegelabgeleiteter Verbindungen vom Labor in die klinische Anwendung.

3.263 Artikel

Klinische Studien

Randomisierte kontrollierte Studien und systematische Übersichtsarbeiten zu Ergebnissen der Blutegeltherapie.

6.465 Artikel

Sicherheit & Infektionskontrolle

Aeromonas-Überwachung, Prophylaxe-Protokolle und Daten zu unerwünschten Ereignissen.

994 Artikel

Genomik & Proteomik

Omics-basierte Entdeckung neuartiger Speichelproteine des Blutegels und ihrer Funktionen.

807 Artikel

Alle Artikel

Recent research articles carrying original, peer-reviewed ASH analysis. See the full index of all 2,552 analysed articles, or search the complete 10,051-article corpus in the Smart Library (faceted by topic, evidence grade, year, and verification status).

Comparison of bleeding and thrombotic outcomes in veno-venous extracorporeal membrane oxygenation: Heparin versus bivalirudin

Arzneimittelentwicklung

Kartika et al. (2024) — European journal of haematology

Peer-reviewed pharmacology and drug-development research relevant to anticoagulants and leech-derived compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices

Arzneimittelentwicklung

Pappalardo et al. (2012) — Minerva anestesiologica

Peer-reviewed pharmacology and drug-development research relevant to anticoagulants and leech-derived compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Heparin-induced thrombosis with a normal platelet count

Klinische Studien

Alvarez et al. (2007) — Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Effects of Bivalirudin and Unfractionated Heparin on Liver and Renal Function in Chinese Patients with Coronary Artery Disease Undergoing Coronary Angiography with/without Percutaneous Coronary Intervention

Arzneimittelentwicklung

Jia et al. (2021) — Journal of clinical and translational hepatology

Peer-reviewed pharmacology and drug-development research relevant to anticoagulants and leech-derived compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Association Between Argatroban and Outcomes of Branch Atheromatous Disease: A Propensity-Matched Analysis From MRI-Based Study

Arzneimittelentwicklung

Li et al. (2025) — CNS neuroscience & therapeutics

Peer-reviewed pharmacology and drug-development research relevant to anticoagulants and leech-derived compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Safety and efficacy of argatroban combined with antiplatelet therapy for acute mild-to-moderate ischemic stroke with large artery atherosclerosis

Arzneimittelentwicklung

Yan et al. (2025) — Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

Peer-reviewed pharmacology and drug-development research relevant to anticoagulants and leech-derived compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Delayed-onset eptifibatide-induced thrombocytopenia

Klinische Studien

Huffman et al. (2024) — American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Clinical impact of kidney function in patients with atrial fibrillation receiving oral anticoagulants

Klinische Studien

Matsuoka et al. (2025) — International journal of cardiology

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Renal outcomes following oral anticoagulation in non-valvular atrial fibrillation: A multicentre, propensity-matched retrospective analysis in an Asian population

Klinische Studien

Koh et al. (2025) — Asian cardiovascular & thoracic annals

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Effectiveness and Safety in Patients with Non-Valvular Atrial Fibrillation Who Switched from Warfarin to Direct Oral Anticoagulants in Medicare Population

Klinische Studien

Atreja et al. (2025) — Advances in therapy

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Population pharmacokinetics of unfractionated heparin and multivariable analysis of activated clotting time in patients undergoing radiofrequency ablation of atrial fibrillation

Arzneimittelentwicklung

Konecki et al. (2024) — Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Peer-reviewed pharmacology and drug-development research relevant to anticoagulants and leech-derived compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Bleeding Associated With Antiarrhythmic Drugs in Patients With Atrial Fibrillation Using Direct Oral Anticoagulants: A Nationwide Population Cohort Study

Klinische Studien

Wu et al. (2024) — Journal of the American Heart Association

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Comparing Efficacy and Safety of Different Anticoagulants in Cerebral Venous Thrombosis: A Systematic Review and Network Meta-Analysis

Klinische Studien

Waseem et al. (2026) — Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

PROS1 (Cys228Tyr) missense mutation associated with mesenteric and pulmonary venous thromboembolism during the COVID-19 pandemic: a case report

Klinische Studien

Huang et al. (2025) — Frontiers in cardiovascular medicine

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Comparison of VTE prophylaxis agents on hemoglobin levels after total knee arthroplasty: a hospital information system-based observational study

Sicherheit & Infektionskontrolle

Yuan et al. (2025) — Journal of orthopaedic surgery and research

Peer-reviewed safety and infection-control research relevant to leech therapy and microsurgical wound management. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Upper Extremity Deep Vein Thrombosis Secondary to Gastric Cancer: A Case Report

Klinische Studien

Takano et al. (2026) — Cureus

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical management

Klinische Studien

Riess et al. (2021) — Critical reviews in oncology/hematology

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

An update on the efficacy and safety of novel anticoagulants for cancer associated thrombosis

Klinische Studien

Cosmi (2021) — Expert opinion on pharmacotherapy

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Efficacy and safety of Xa inhibitors for the treatment of cancer-associated venous thromboembolism

Arzneimittelentwicklung

Kimpton et al. (2019) — Expert opinion on drug safety

Peer-reviewed pharmacology and drug-development research relevant to anticoagulants and leech-derived compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Peak and Trough Concentration Ranges of Factor Xa Inhibitors for Preventing Thromboembolic Stroke in Korean Patients with Non-valvular Atrial Fibrillation

Arzneimittelentwicklung

Park et al. (2026) — Annals of laboratory medicine

Peer-reviewed pharmacology and drug-development research relevant to anticoagulants and leech-derived compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Real-world evidence comparing oral anticoagulants for NVAF in Europe: a systematic review and network meta-analysis

Klinische Studien

Cichewicz et al. (2025) — Future cardiology

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Edoxaban-Induced Vanishing Bile Duct Syndrome: A Case Report With Review of the Literature

Arzneimittelentwicklung

Borgonovo et al. (2024) — Cureus

Peer-reviewed pharmacology and drug-development research relevant to anticoagulants and leech-derived compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Optimizing warfarin dosing for patients with atrial fibrillation using machine learning

Arzneimittelentwicklung

Petch et al. (2024) — Scientific reports

Peer-reviewed pharmacology and drug-development research relevant to anticoagulants and leech-derived compounds. Indexed in PubMed and verified against the NCBI record.

Analyse lesen →

Leech-borne Serratia marcescens infection following complex hand injury.

Sicherheit & Infektionskontrolle

Pereira et al. (1998) — British journal of plastic surgery

Leeches are commonly used in the postoperative course of plastic surgical operations where there is venous congestion in a pedicled or free flap. They provide a temporary relief to venous engorgement whilst venous drainage is re-established.

Analyse lesen →

Eine Publikation zur Begutachtung vorschlagen

Kennen Sie eine relevante Publikation zur Hirudotherapie? Wir nehmen Vorschläge für unsere Forschungsbibliothek gerne entgegen.

Kontaktieren Sie uns →

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.